In this free webinar, learn how direct-to-patient strategies and patient-centric supply chain solutions can enhance clinical trial diversity. Attendees will learn how patient centricity can significantly enhance patient experience and enrollment. The featured speakers will discuss the challenges of leveraging patient insurance and how innovative approaches can alleviate financial burdens.
TORONTO, Sept. 12, 2024 /PRNewswire-PRWeb/ -- This webinar will explore the latest trends in the clinical trial industry, emphasizing direct-to-patient trial strategies and their impact on diversity, equity and inclusion (DEI). Reaching marginalized communities is a critical component for fulfilling study enrollment, yet these communities often face unique challenges.
One significant hurdle is the financial burden placed on patients due to the leveraging of patient insurance, which can hinder study enrollment and impact efforts to improve clinical trial diversity in the United States. Current industry trends are centered on patient-centric approaches such as DEI, accelerated start-up timelines and decentralized clinical trials.
Prioritizing patient-centricity can significantly enhance patient experience and enrollment, leading to more successful clinical trials. In addition, as clinical trial sites manage numerous studies simultaneously, it is essential to develop supply strategies that simplify the management of investigational medicinal products (IMPs) and non-IMPs (NIMPs).
This webinar will dive into how patient-centric supply strategies can address these complexities, improve trial efficiency and support clinical trial diversity. Through case studies, the featured speakers will examine various sourcing options for sponsors, highlighting their benefits and drawbacks for sponsors, patients and sites. Additionally, the discussion will cover how comparator drug supply vendors handle complex trial designs and access to specialty drugs, ensuring that patient needs are met efficiently.
Register for this webinar to learn about innovative, on-demand local sourcing solutions, methods to minimize cost and waste in clinical trials and how clinical trial diversity can benefit both sites and patients.
Join experts from Myonex, Samit Bhatt, Vice President, Clinical Trial Patient Solutions; and Todd Luckritz, Associate Director, Clinical Trial Patient Solutions, for the live webinar on Thursday, September 26, 2024, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Bridging the Gap: Direct-to-Patient Strategies to Support Diversity in Clinical Trials.
ABOUT MYONEX
Myonex is a leading global complete clinical trial supply company offering tailored solutions in central and local drug sourcing, packaging, labeling, and ancillary and equipment supply to support each trial's specific requirements and complexities. With nine locations in the US, Germany, UK & France, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), and other clinical trial service providers seeking a flexible, comprehensive solution for their trial supply needs. Learn more at http://www.myonex.com.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article